Emergent BioSolutions has partnered with British Columbia's Provincial Health Services Authority to supply NARCAN Nasal Spray for the expanded Take-Home Naloxone Program, backed by an $18 million CAD investment. This expansion follows a successful pilot that distributed 60,000 nasal naloxone kits to various community sites. NARCAN Nasal Spray rapidly reverses opioid overdoses and is available at no cost in several Canadian provinces and territories. The partnership aims to increase access and awareness to combat the opioid crisis across Canada effectively.
Heilind Electronics announced the availability of the Brady i4311 Industrial Label Printer, a portable, cordless printer that combines benchtop-quality wide-format printing with all-day battery life and ergonomic design. Weighing 13 lbs and capable o...
The American Kidney Fund (AKF) has launched a new online course on lupus nephritis through its Kidney Health Coach program. This initiative aims to educate both community members and healthcare professionals about the symptoms, testing, diagnosis, tr...
The global Edge AI software market is projected to grow from $2.40 billion in 2025 to $8.89 billion by 2031, at a CAGR of 24.4%. This growth is fueled by rising demand for real-time AI decision-making, localized data processing, and intelligent edge ...
Leon Aryah Lewis, a Los Angeles-based mystic, has published his debut book "Inside Out: A Journey of the Soul," which he wrote three decades ago but only recently released. The book blends memoir and spiritual reflections, exploring themes like reinc...
A director at Flywire has sold 6,524 shares of the company's stock, totaling approximately $92,000. This insider sale may indicate personal financial decisions or a shift in confidence, which investors often watch closely. While not necessarily a sig...
